Search filters

List of works by Zong Sheng Guo

A Rationally Designed A34R Mutant Oncolytic Poxvirus: Improved Efficacy in Peritoneal Carcinomatosis

scientific article published on February 26, 2013

Aldo-keto reductase-7A protects liver cells and tissues from acetaminophen-induced oxidative stress and hepatotoxicity

scientific article published on 06 September 2011

Bi- and Tri-Specific T Cell Engager-Armed Oncolytic Viruses: Next-Generation Cancer Immunotherapy

scientific article published on 10 July 2020

Chronic Anti-inflammatory Drug Therapy Inhibits Gel-Forming Mucin Production in a Murine Xenograft Model of Human Pseudomyxoma Peritonei

scientific article published on May 1, 2012

Editorial of the Special Issue: Oncolytic Viruses as a Novel Form of Immunotherapy for Cancer.

scientific article

Homeobox gene Rhox5 is regulated by epigenetic mechanisms in cancer and stem cells and promotes cancer growth

scientific article published on May 24, 2011

IL-36γ-armed oncolytic virus exerts superior efficacy through induction of potent adaptive antitumor immunity

scientific article published on 04 February 2021

Inhibitors of C5 complement enhance vaccinia virus oncolysis

scientific article published on May 10, 2013

Lentivector Prime and Vaccinia Virus Vector Boost Generate High-Quality CD8 Memory T Cells and Prevent Autochthonous Mouse Melanoma

scientific article published on July 11, 2011

Life after death: targeting high mobility group box 1 in emergent cancer therapies

scientific article published on January 18, 2013

Modifying the cancer-immune set point using vaccinia virus expressing re-designed interleukin-2

scientific article published in Nature Communications

Mucin as a therapeutic target in pseudomyxoma peritonei

scientific article published on May 14, 2012

Oncolytic poxvirus armed with Fas ligand leads to induction of cellular Fas receptor and selective viral replication in FasR-negative cancer

scientific article published on November 25, 2011

Oncolytic virus promotes tumor-reactive infiltrating lymphocytes for adoptive cell therapy

scientific article published on 07 July 2020

PARK7 modulates autophagic proteolysis through binding to the N-terminally arginylated form of the molecular chaperone HSPA5

scientific article published on 23 July 2018

Phase 1 Study of Intravenous Oncolytic Poxvirus (vvDD) in Patients With Advanced Solid Cancers

scientific article published on 16 May 2016

Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy

scientific article published on 27 March 2017

Synergistic Combination of Oncolytic Virotherapy and Immunotherapy for Glioma

scientific article published on 04 February 2020

The 2018 Nobel Prize in medicine goes to cancer immunotherapy (editorial for BMC cancer)

The efficacy of adenovirus-mediated gene therapy of ovarian cancer is enhanced by using the cytomegalovirus promoter

scientific article published on March 1, 1998

Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics

scholarly article by Zong Sheng Guo et al published 9 January 2019 in Journal for Immunotherapy of Cancer

miR-574-5p negatively regulatesQki6/7to impactβ-catenin/Wnt signalling and the development of colorectal cancer

scientific article published on April 5, 2012